申请人:Hoechst Marion Roussel, Inc.
公开号:US06114572A1
公开(公告)日:2000-09-05
The present invention provides compounds of the formula ##STR1## wherein X is selected from the group consisting of ##STR2## Y is thio, oxy or a methylene group; Z is hydrogen or --C(O)--(CH.sub.2).sub.m --Q wherein Q is hydrogen or --COOH and m is an integer 1, 2, 3 or 4; R.sub.1 is C.sub.1 -C.sub.6 alkyl; and R.sub.2, R.sub.3 and R.sub.4 are each independently hydrogen or C.sub.1 -C.sub.6 alkyl; or a stereoisomer thereof; useful for the treatment of atherosclerosis and chronic inflammatory disorders; for inhibiting cytokine-induced expression of VCAM-1 and/or ICAM-1; for inhibiting the peroxidation of LDL lipid; for lowering plasma cholesterol; and as anti-oxidant chemical additives useful for preventing oxidative deterioration in organic materials.
本发明提供了以下结构的化合物:其中X选择自##STR2##,Y是硫、氧或亚甲基基团;Z是氢或--C(O)--(CH.sub.2).sub.m --Q,其中Q是氢或--COOH,m是整数1、2、3或4;R.sub.1是C.sub.1 -C.sub.6烷基;R.sub.2、R.sub.3和R.sub.4各自独立地是氢或C.sub.1 -C.sub.6烷基;或其立体异构体;用于治疗动脉粥样硬化和慢性炎症性疾病;用于抑制细胞因子诱导的VCAM-1和/或ICAM-1的表达;用于抑制LDL脂质的过氧化作用;用于降低血浆胆固醇;以及作为抗氧化剂化学添加剂,可用于预防有机材料的氧化恶化。